European API Market will experience a noticeable growth during the forecast period 2019-2025

The European API market is estimated to witness a growth rate of around 6.0% over the period of 2019-2025. Significant market for API is witnessed in the region owing to the presence of several pharmaceutical and biopharmaceutical drug manufacturing companies in the major economies of the region. Europe consists of some of the major pharmaceutical companies inclusding GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, B. Braun Medical Inc., and Evotec AG that are investing significantly in the R&D.

Request a Free Sample of our Report on European API Market: https://www.omrglobal.com/request-sample/european-api-market

The increased focus of market players on the R&D would significantly contribute to the growth of European drug which ultimately generates demand for API. Increasing drug discovery and research, and surging demand for innovative drugs is pushing several pharmaceutical and biopharmaceutical drug manufacturers of the region to invest in the R&D.

The European API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the European API market. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. NSAIDs therapeutics segment held the leading position in 2018.

A Full Report of European API Market is Available at https://www.omrglobal.com/industry-reports/european-api-market

European API Market Segmentation

By Type
o General API
o Branded API

By Type of Synthesis
o Biotech API
o Synthetic API
o Others (High Potency API)

By Therapeutics
o Cardiovascular Drugs
o Oncology Drugs
o Neurology Drugs
o Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
o Others (Orthopedic Drugs)

Regional Analysis
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe

Company Profiles
o AbbVie Inc.
o Aesica Pharmaceuticals, Ltd.
o Almac group PLC
o AstraZeneca PLC
o Aurobindo Pharma Ltd.
o Boehringer Ingelheim International GmbH
o Cambrex Corp.
o Cipla Ltd.
o CordenPharma GmbH
o EsteveQuímica, S.A.
o Fareva SA
o Pfizer, Inc.
o Novartis International AG
o Sanofi SA
o Bristol-Myers Squibb Co.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-api-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.